Skip to main content

Find Clinical Trials

Home
Conditions
Myeloma

Clinical trial condition

Myeloma

Explore clinical trials studying Myeloma. Study availability and eligibility vary by location and protocol.

115 public trials 23 recruiting studies

Refine in advanced search Browse all conditions

Myeloma trial results

Completed

Study Comparing Conventional Dose Combination RVD to High-Dose Treatment With ASCT in the Initial Myeloma up to 65 Years

NCT01191060

Conditions: Disease Attributes, Disease Progression, Myeloma, +5 more
Locations: CH du Pays D'Aix Aix-en-Provence, France

CHRU - Hôpital Sud Amiens Amiens, France

CHU d'Angers Angers, France

Centre Hospitalier Argenteuil Victor Dupouy Argenteuil, France

View all 68 locations

View Trial Details

Completed

Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy

NCT05763563

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Completed

Removing Transfusion Dependence as a Barrier to Hospice Enrollment

NCT05063591

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +17 more
Locations: Rhode Island Hospital Providence, Rhode Island, United States

View Trial Details

Completed

Non-invasive MRD Assessment in Multiple Myeloma

NCT05625971

Conditions: Myeloma, Neoplasm, Residual, Neoplasms, +5 more
Locations: New York Presbyterian Hospital/Columbia University Irving Medical Center New York, United States

View Trial Details

Completed

A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.

NCT05228470

Conditions: BCMA, BCMA-CD3 Bispecific, Bispecific, +23 more
Locations: Fujian Medical University Union Hospital Fuzhou, Fujian, China

Guangdong Provincial People's Hospital Guangzhou, Guangdong, China

Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China

Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View all 15 locations

View Trial Details

Completed

Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults

NCT04952766

Conditions: Acquired Immunodeficiency Syndrome, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +44 more
Locations: CHU Orléans Orléans, France

View Trial Details

Completed

Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning

NCT00466674

Conditions: Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
Locations: Mohamad Sobh Lyon, France

View Trial Details

Completed

FT576 in Subjects With Multiple Myeloma

NCT05182073

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

City of Hope Duarte, California, United States

Scri-Cbci Denver, Colorado, United States

Medical Oncology Hematology Consultants Newark, Delaware, United States

View all 14 locations

View Trial Details

Completed

Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy

NCT05065866

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +15 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Completed

Stem Cell Transplantation for Patients With Multiple Myeloma

NCT01526096

Conditions: Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details